These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 23356422)

  • 1. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
    J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
    Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
    Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Buse DC; Saiers J; Fanning KM; Serrano D; Reed ML
    Headache; 2013 Jan; 53(1):93-103. PubMed ID: 23148774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Loder EW; Gorman JA; Stewart WF; Reed ML; Fanning KM; Serrano D; Lipton RB
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Martin VT; Fanning KM; Serrano D; Buse DC; Reed ML; Bernstein JA; Lipton RB
    Cephalalgia; 2014 Apr; 34(5):336-48. PubMed ID: 24275145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Serrano D; Holland S; Reed ML
    Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.
    Smitherman TA; Burch R; Sheikh H; Loder E
    Headache; 2013 Mar; 53(3):427-36. PubMed ID: 23470015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
    Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
    Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain, health related quality of life and healthcare resource utilization in Spain.
    Langley P; Pérez Hernández C; Margarit Ferri C; Ruiz Hidalgo D; Lubián López M
    J Med Econ; 2011; 14(5):628-38. PubMed ID: 21882904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain among children and adolescents: restrictions in daily living and triggering factors.
    Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
    Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.